186 related articles for article (PubMed ID: 26306069)
1. Does Profile of Hemoglobin Eβ-thalassemia Patients Change After Splenectomy? Experience of a Tertiary Thalassemia Care Centre in Eastern India.
Mandal PK; Ghosh MK; Bhattacharyya M
Indian J Hematol Blood Transfus; 2015 Dec; 31(4):446-52. PubMed ID: 26306069
[TBL] [Abstract][Full Text] [Related]
2. Chelation therapy in beta-thalassemia major. III. The role of splenectomy in achieving iron balance.
Graziano JH; Piomelli S; Hilgartner M; Giardina P; Karpatkin M; Andrew M; LoIacono N; Seaman C
J Pediatr; 1981 Nov; 99(5):695-9. PubMed ID: 7299540
[TBL] [Abstract][Full Text] [Related]
3. Final Height and Endocrine Complications in Patients with β-Thalassemia Intermedia: Our Experience in Non-Transfused Versus Infrequently Transfused Patients and Correlations with Liver Iron Content.
Yassin MA; Soliman AT; De Sanctis V; Yassin KS; Abdulla MA
Mediterr J Hematol Infect Dis; 2019; 11(1):e2019026. PubMed ID: 31205630
[TBL] [Abstract][Full Text] [Related]
4. Thalassemia.
Cohen AR; Galanello R; Pennell DJ; Cunningham MJ; Vichinsky E
Hematology Am Soc Hematol Educ Program; 2004; ():14-34. PubMed ID: 15561674
[TBL] [Abstract][Full Text] [Related]
5. [Current management of thalassemia intermedia].
Thuret I
Transfus Clin Biol; 2014 Nov; 21(4-5):143-9. PubMed ID: 25282488
[TBL] [Abstract][Full Text] [Related]
6. Post Splenectomy Outcome in β-Thalassemia.
Merchant RH; Shah AR; Ahmad J; Karnik A; Rai N
Indian J Pediatr; 2015 Dec; 82(12):1097-100. PubMed ID: 26099360
[TBL] [Abstract][Full Text] [Related]
7. Do Transfusion Dependent E-Βeta Thalassemics Behave Differently from Patients with Βeta-Thalassemia Major?
Sen S; Mohapatra R; Chakrabarti P
Indian J Hematol Blood Transfus; 2021 Oct; 37(4):664-668. PubMed ID: 34744349
[TBL] [Abstract][Full Text] [Related]
8. Treatment with hydroxyurea in thalassemia intermedia with paravertebral pseudotumors of extramedullary hematopoiesis.
Cario H; Wegener M; Debatin KM; Kohne E
Ann Hematol; 2002 Aug; 81(8):478-82. PubMed ID: 12224008
[TBL] [Abstract][Full Text] [Related]
9. Vascular and hemostatic alterations associated with pulmonary hypertension in β-thalassemia hemoglobin E patients receiving regular transfusion and iron chelation.
Uaprasert N; Satitthummanid S; Akkawat B; Sutcharitchan P; Rojnuckarin P
Thromb Res; 2019 Feb; 174():104-112. PubMed ID: 30584959
[TBL] [Abstract][Full Text] [Related]
10. Cardiovascular effects of splenomegaly and splenectomy in beta-thalassemia.
Aessopos A; Farmakis D; Deftereos S; Tsironi M; Polonifi A; Moyssakis I; Diamanti-Kandaraki E; Papalambros E
Ann Hematol; 2005 Jun; 84(6):353-7. PubMed ID: 15711802
[TBL] [Abstract][Full Text] [Related]
11. Response to hydroxycarbamide in pediatric β-thalassemia intermedia: 8 years' follow-up in Egypt.
El-Beshlawy A; El-Ghamrawy M; EL-Ela MA; Said F; Adolf S; Abdel-Razek AR; Magdy RI; Abdel-Salam A
Ann Hematol; 2014 Dec; 93(12):2045-50. PubMed ID: 25062719
[TBL] [Abstract][Full Text] [Related]
12. Platelet Aggregation Study in Patients With Hemoglobin Eβ Thalassemia in India.
Ghosal T; Dolai TK; Mandal PK; Karthik S; Bandyopadhyay A
Clin Appl Thromb Hemost; 2016 Sep; 22(6):575-80. PubMed ID: 25701765
[TBL] [Abstract][Full Text] [Related]
13. Contemporary approaches to treatment of beta-thalassemia intermedia.
Taher AT; Musallam KM; Karimi M; Cappellini MD
Blood Rev; 2012 Apr; 26 Suppl 1():S24-7. PubMed ID: 22631038
[TBL] [Abstract][Full Text] [Related]
14. [Thalassemia intermedia: 36 cases].
Hafsia R; Ben Salah N; Hafhouf E; Belakhal F; Gouider E; El Borji W; Meddeb B
Tunis Med; 2010 Feb; 88(2):102-4. PubMed ID: 20415168
[TBL] [Abstract][Full Text] [Related]
15. Extramedullary hematopoiesis-related pleural effusion: the case of beta-thalassemia.
Aessopos A; Tassiopoulos S; Farmakis D; Moyssakis I; Kati M; Polonifi K; Tsironi M
Ann Thorac Surg; 2006 Jun; 81(6):2037-43. PubMed ID: 16731126
[TBL] [Abstract][Full Text] [Related]
16. Splenectomy in homozygous beta thalassaemia: a retrospective study of 30 patients.
Engelhard D; Cividalli G; Rachmilewitz EA
Br J Haematol; 1975 Nov; 31(3):391-403. PubMed ID: 1201250
[TBL] [Abstract][Full Text] [Related]
17. Iron metabolism in thalassemia intermedia.
Fiorelli G; Fargion S; Piperno A; Battafarano N; Cappellini MD
Haematologica; 1990; 75 Suppl 5():89-95. PubMed ID: 2086386
[TBL] [Abstract][Full Text] [Related]
18. Coagulation and splenectomy: an overview.
Cappellini MD; Grespi E; Cassinerio E; Bignamini D; Fiorelli G
Ann N Y Acad Sci; 2005; 1054():317-24. PubMed ID: 16339680
[TBL] [Abstract][Full Text] [Related]
19. Long-term Results of Splenectomy in Transfusion-dependent Thalassemia.
Akca T; Ozdemir GN; Aycicek A; Ozkaya G
J Pediatr Hematol Oncol; 2023 Apr; 45(3):143-148. PubMed ID: 35446800
[TBL] [Abstract][Full Text] [Related]
20. [Monitoring and appraisal of the effects of blood transfusion and iron chelation in thalassemia major].
Girot R; Triadou P; Bories D; Jeannel F; Thevenin M; Rymer JC
Nouv Rev Fr Hematol (1978); 1982; 24(5):281-7. PubMed ID: 7167380
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
